Frontotemporal Dementia Market Size
Market Size in USD Bn
CAGR6.1%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 6.1% |
| Market Concentration | High |
| Major Players | Alector, Transposon Therapeutics, AviadoBio, Vesper Bio, GSK and Among Others |
please let us know !
Frontotemporal Dementia Market Analysis
The Global Frontotemporal Dementia Market is estimated to be valued at USD 12.93 Billion in 2025 and is expected to reach USD 19.57 Billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032. The rising prevalence of Frontotemporal Dementia around the world due to an aging global population as well as improving diagnostics is driving the growth of this market.
The market is witnessing positive growth trends with increased research and development activities focusing on development of new biomarkers and diagnostic technologies for early diagnosis. Several ongoing clinical trials evaluating new drugs for disease modifying therapy are also supporting market growth. Improving awareness about the illness as well as availability of several promising pipeline drugs will continue to provide opportunities for the Frontotemporal Dementia market in the forecast period.